Intermediate Term Effect of Captopril on Left Ventricle Global Longitudinal Strain in Patients With Duchenne Myodystrophy
| Registry | NCT06485661 |
|---|---|
| Status | Unknown |
| Phase | Early Phase 1 |
| Study type | Interventional; na, single group, masking: none, treatment |
| Enrollment | 20 (Estimated) |
| Sponsor | Ain Shams University (Other) |
| Conditions | Effect of Drug |
| Interventions | Captopril Tablets (Drug) |
| Dates | start 2024-01-01, primary completion 2024-09-30 (estimated), completion 2024-09-30 (estimated), first posted 2024-07-03, last updated 2024-07-16 |
| Locations | 1 site in Egypt |
Related Papers Related Patents Related Grants Related Experts
All trials for Effect of Drug All trials of Captopril Tablets
To outline the intermediate term effect of prescribing Captopril as an add on therapy on Left ventricular functions as measured by Global longitudinal strain in patients with Duchenne myodystrophy (DMD)
ACEI slowing down the onset and the progression of dystrophinopathic cardiomyopathy.
To outline the intermediate term effect of prescribing Captopril as an add on therapy on Left ventricular functions as measured by Global longitudinal strain in patients with Duchenne myodystrophy (DMD
| Arm | Type | Interventions | Description |
|---|---|---|---|
| Duchenne patients subjected to captopril | Other | Drug: Captopril Tablets |
Sex: Male, ages: 6 Years to any
Inclusion Criteria: * Genetically confirmed Duchenne myodystrophy (DMD) patients with abnormal GLS < -18% with minimum age of 6 years old. Exclusion Criteria: * Any patient who refuses to sign an informed consent. * Contraindication to ACEI: hypersensitivity - renal impairment - bilateral renal artery stenosis - aortic valve stenosis - hyperkalemia - hypotension. * Reduced ejection fraction below 50%.
| Facility | City | Country | Status |
|---|---|---|---|
| Ain Shams university | Cairo | Egypt | Recruiting |